Literature DB >> 28994779

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake.

Kathrine L Jensen1, Annika H Runegaard1, Pia Weikop2, Ulrik Gether1, Mattias Rickhag3.   

Abstract

Dopamine (DA) is a modulatory neurotransmitter controlling motor activity, reward processes and cognitive function. Impairment of dopaminergic (DAergic) neurotransmission is strongly associated with several central nervous system-associated diseases such as Parkinson's disease, attention-deficit-hyperactivity disorder and drug addiction1,2,3,4. Delineating disease mechanisms involving DA imbalance is critically dependent on animal models to mimic aspects of the diseases, and thus protocols that assess specific parts of the DA homeostasis are important to provide novel insights and possible therapeutic targets for these diseases. Here, we present two useful experimental protocols that when combined provide a functional read-out of the DAergic system in mice. Biochemical and functional parameters on DA homeostasis are obtained through assessment of DA levels and dopamine transporter (DAT) functionality5. When investigating the DA system, the ability to reliably measure endogenous levels of DA from adult brain is essential. Therefore, we present how to perform high-performance liquid chromatography (HPLC) on brain tissue from mice to determine levels of DA. We perform the experiment on tissue from dorsal striatum (dStr) and nucleus accumbens (NAc), but the method is also suitable for other DA-innervated brain areas. DAT is essential for reuptake of DA into the presynaptic terminal, thereby controlling the temporal and spatial activity of released DA. Knowing the levels and functionality of DAT in the striatum is of major importance when assessing DA homeostasis. Here, we provide a protocol that allows to simultaneously deduce information on surface levels and function using a synaptosomal6 DA uptake assay. Current methods combined with standard immunoblotting protocols provide the researcher with relevant tools to characterize the DAergic system.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28994779      PMCID: PMC5752313          DOI: 10.3791/56093

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  38 in total

1.  Real-time measurements of phasic changes in extracellular dopamine concentration in freely moving rats by fast-scan cyclic voltammetry.

Authors:  Paul E M Phillips; Donita L Robinson; Garret D Stuber; Regina M Carelli; R Mark Wightman
Journal:  Methods Mol Med       Date:  2003

2.  L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease.

Authors:  Philippe Huot; Tom H Johnston; James B Koprich; Susan H Fox; Jonathan M Brotchie
Journal:  Neuropharmacology       Date:  2012-06-18       Impact factor: 5.250

3.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

Review 4.  Thirty years of synaptosome research.

Authors:  V P Whittaker
Journal:  J Neurocytol       Date:  1993-09

5.  Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.

Authors:  Paul D Callaghan; Rodney J Irvine; Lynette C Daws
Journal:  Neurochem Int       Date:  2005-10       Impact factor: 3.921

6.  Comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental area.

Authors:  Michael F Salvatore; Brandon S Pruett; Charles Dempsey; Victoria Fields
Journal:  J Vis Exp       Date:  2012-08-10       Impact factor: 1.355

Review 7.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

Review 8.  Monoamine transporters: from genes to behavior.

Authors:  Raul R Gainetdinov; Marc G Caron
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-09-17       Impact factor: 13.820

Review 9.  Behavioral dopamine signals.

Authors:  Wolfram Schultz
Journal:  Trends Neurosci       Date:  2007-04-02       Impact factor: 13.837

10.  A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter.

Authors:  Mattias Rickhag; Freja Herborg Hansen; Gunnar Sørensen; Kristine Nørgaard Strandfelt; Bjørn Andresen; Kamil Gotfryd; Kenneth L Madsen; Ib Vestergaard-Klewe; Ina Ammendrup-Johnsen; Jacob Eriksen; Amy H Newman; Ernst-Martin Füchtbauer; Jesus Gomeza; David P D Woldbye; Gitta Wörtwein; Ulrik Gether
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  4 in total

1.  Esophagus tissue engineering: from decellularization to in vivo recellularization in two sites.

Authors:  Sahar Eftekharzadeh; Aram Akbarzadeh; Nastaran Sabetkish; Minoo Rostami; Amir Hossein Zabolian; Javad Hashemi; Seyed Mohammad Tavangar; Abdol-Mohammad Kajbafzadeh
Journal:  Cell Tissue Bank       Date:  2021-08-19       Impact factor: 1.522

2.  Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.

Authors:  Freja Herborg; Kathrine L Jensen; Sasha Tolstoy; Natascha V Arends; Leonie P Posselt; Aparna Shekar; Jenny I Aguilar; Viktor K Lund; Kevin Erreger; Mattias Rickhag; Matthew D Lycas; Markus N Lonsdale; Troels Rahbek-Clemmensen; Andreas T Sørensen; Amy H Newman; Annemette Løkkegaard; Ole Kjærulff; Thomas Werge; Lisbeth B Møller; Heinrich Jg Matthies; Aurelio Galli; Lena E Hjermind; Ulrik Gether
Journal:  JCI Insight       Date:  2021-09-22

3.  PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis.

Authors:  Kathrine Louise Jensen; Gunnar Sørensen; Ditte Dencker; William Anthony Owens; Troels Rahbek-Clemmensen; Michael Brett Lever; Annika H Runegaard; Nikolaj Riis Christensen; Pia Weikop; Gitta Wörtwein; Anders Fink-Jensen; Kenneth L Madsen; Lynette Daws; Ulrik Gether; Mattias Rickhag
Journal:  eNeuro       Date:  2018-06-11

4.  Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent.

Authors:  Mathias E Jensen; Aurelio Galli; Morgane Thomsen; Kathrine L Jensen; Gerda K Thomsen; Mette K Klausen; Tina Vilsbøll; Mikkel B Christensen; Jens J Holst; Anthony Owens; Sabrina Robertson; Lynette Daws; Daniele Zanella; Ulrik Gether; Gitte M Knudsen; Anders Fink-Jensen
Journal:  Neurochem Int       Date:  2020-05-25       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.